Abacus Life, Inc. (NASDAQ:ABL – Get Free Report) saw a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 770,200 shares, a growth of 14.7% from the October 15th total of 671,700 shares. Based on an average trading volume of 87,600 shares, the short-interest ratio is presently 8.8 days. Currently, 6.1% of the shares of the stock are short sold.
Abacus Life Stock Down 1.7 %
Abacus Life stock opened at $8.34 on Friday. The firm has a market cap of $622.58 million, a price-to-earnings ratio of -46.33 and a beta of 0.15. Abacus Life has a 52-week low of $5.85 and a 52-week high of $13.25. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a 50 day moving average price of $9.46 and a two-hundred day moving average price of $9.95.
Abacus Life (NASDAQ:ABL – Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.06. The company had revenue of $28.15 million during the quarter, compared to analysts’ expectations of $26.08 million. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%. During the same period in the prior year, the company posted $0.01 earnings per share. Equities analysts predict that Abacus Life will post 0.6 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
A number of analysts have recently commented on the company. B. Riley Financial reissued a “buy” rating and set a $16.00 price target on shares of Abacus Life in a research note on Friday, August 30th. Piper Sandler reiterated an “overweight” rating and set a $13.00 target price (up from $12.00) on shares of Abacus Life in a research report on Friday, November 8th. Northland Securities started coverage on shares of Abacus Life in a report on Thursday, October 24th. They set an “outperform” rating and a $13.50 target price on the stock. B. Riley reaffirmed a “buy” rating and set a $16.00 price target (up previously from $15.00) on shares of Abacus Life in a research note on Thursday, August 29th. Finally, Northland Capmk raised shares of Abacus Life to a “strong-buy” rating in a research note on Thursday, October 24th. Five investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Abacus Life has an average rating of “Buy” and a consensus price target of $14.50.
Get Our Latest Stock Analysis on Abacus Life
About Abacus Life
Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.
Further Reading
- Five stocks we like better than Abacus Life
- Are Penny Stocks a Good Fit for Your Portfolio?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Stock Market Sectors: What Are They and How Many Are There?
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Time to Load Up on Home Builders?
Receive News & Ratings for Abacus Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Life and related companies with MarketBeat.com's FREE daily email newsletter.